BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

TACLONEX Pages on BioPortfolio:

Biotechnology News TACLONEX Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/TACLONEX-news.htm...

BioPortfolio - Taclonex
Taclonex - BioPortfolio - Indepth. ... Companies working in the area of Taclonex from Bioportfolio's Biocorporate database : BioPortfolio Logo. Company Name ...
http://www.bioportfolio.com/indepth/Taclonex.html...

BioPortfolio's Approved Drugs News by Tradename - T to Th
... News updated every 20 minutes from thousands of internet sites. Click the link below to view the latest news: TAB-PROFEN · TACARYL · TACE · TACLONEX ...
http://www.bioportfolio.co.uk/approved_drugs/approved_drug_n...

BioPortfolio - Warner Chilcott
We strengthened and extended our position in the market for psoriasis therapies with the April 2006 launch of Taclonex® the first once-a-day topical ...
http://www.bioportfolio.com/biocorporate/10947-Warner_Chilco...

BioPortfolio's Approved Drugs News by Tradename - T to Th
Approved Drug Profile Alphabetical listing by Tradename - "T to Th" Click the link below to view profiles: TAB-PROFEN · TACARYL · TACE · TACLONEX ...
http://www.bioportfolio.co.uk/approved_drugs/approved_drug_p...

The Dermatology Market Outlook to 2013: Competitive landscape ...
... treatments is forecast to register strong growth between 2008-2013, driven by the performances of key drugs such as Raptiva, Taclonex, Soriatane. ...
http://www.bioportfolio.com/cgi-bin/acatalog/The-Dermatology...

BioPortfolio News: Warner Chilcott plc - Warner Chilcott Reports ...
Net sales of TACLONEX decreased $9.2 million, or 24.0%, to $29.0 million in the ... The decrease in TACLONEX net sales was primarily due to a contraction in ...
http://www.bioportfolio.com/news/Warner-Chilcott-Reports-Ope...

BioPortfolio Limited The World Dermatological Market Outlook, 2009 ...
7.5 Taclonex Sales Trends 7.5.1 Dovonex/Daivobet/Taclonex (calciportiene/ betamethasone) .... Figure 7.8 Taclonex Revenue Forecast ($m), 2008-2023 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_361.html...

BioPortfolio Limited The Dermatology Market Outlook to 2013 ...
Taclonex 107. Drugs in registration 108. Ustekinumab (CNTO–1275) 108. Panaclar/ BG-12 110 .... Table 4.42: An overview of Taclonex 107 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_1130.html...

BioPortfolio - Indepth Browse
... Tachycardia | Tachycardia Ventricular | Tachyphylaxis | Tachypnea Breathing Problems | Taclonex | Tacrolimus Binding Protein 1a | Tacrolimus Binding ...
http://www.bioportfolio.com/indepth/search/T.htm...

Results from other life science and pharmaceutical sites:

Important Safety Information about Taclonex Scalpо Topical ...
Taclonex Scalpо is for the treatment of moderate to severe psoriasis ... You should not use Taclonex Scalpо if you have a history of allergy to any of its
...
http://www.wcrx.com/pdfs/TaclonexScalp.pdf...

Taclonex (calcipotriene 0.005% and betamethasone dipropionate ...
Taclonex (calcipotriene 0.005% and betamethasone dipropionate 0.064%) ointment. Abramovits W, Perlmutter A, Gupta AK. Baylor University Medical Center, ...
http://www.ncbi.nlm.nih.gov/pubmed/16687982...

Warner Chilcott And LEO Pharma Release: Taclonex(R) New Dual ...
3 Apr 2006 ... Warner Chilcott and LEO Pharma announced today that Taclonex® (calcipotriene 0.005% and betamethasone dipropionate 0.064%), a once-daily ...
http://www.biospace.com/news_story.aspx?NewsEntityId=14369...

Taclonex(Calcipotriene Hydrate And Betamethasone Dipropionate ...
These highlights do not include all the information needed to use taclonex safely and effectively. See full prescribing information for taclonex. ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=7958...

LEO SARATH
LEO Pharma submitted the NDA for Taclonex Scalp® to the FDA in July 2007. ... As a result of the FDA approval of Taclonex Scalp®, Warner Chilcott will pay a ...
http://www.leo-sarath.com/index.asp?a_id=2163&n_id=76...

FDA Approves Warner Chilcott's And LEO Pharma's Taclonex(R) - Once ...
LEO Pharma submitted the NDA for Taclonex® to the FDA in March 2005. Taclonex® is a topical ointment containing a combination of calcipotriene 0.005% and ...
http://www.biospace.com/news_story.aspx?NewsEntityId=6564...

taclonex (calcipotriene hydrate and betamethasone dipropionate ...
Each gram of Taclonex® Ointment contains 52.18 mcg of calcipotriene hydrate ( equivalent to 50 mcg of calcipotriene) and 0.643 mg of betamethasone ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=7245...

FDA Approves Warner Chilcott's Taclonex Scalp(R), Once Daily ...
13 May 2008 ... LEO Pharma submitted the NDA for Taclonex Scalp(R) to the FDA in July 2007. Taclonex Scalp(R) is a topical suspension containing a ...
http://www.biospace.com/news_story.aspx?NewsEntityId=96047...

Antipsoriatics - Pharmacy Clinical Policy Bulletins Aetna Medicare ...
Aetna considers Taclonex, Taclonex Scalp and Vectical to be medically ... Aetna considers Dovonex, Oxsoralen (lotion), Taclonex Scalp, Taclonex and Vectical ...
http://www.aetna.com/products/rxmedicare/data/Medicare2009/D...

LEO SARATH
FDA Approves Taclonex Scalp® - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis. Warner Chilcott and LEO Pharma announced 12 May that ...
http://www.leo-sarath.com/...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.